San Donato Hospital
Hodgkin's lymphoma treatment cost in Italy typically includes diagnostic staging like bone marrow puncture with cytogenetic analysis, which runs from $700 to $1,300. Primary treatments such as chemotherapy range from $3,500 to $7,500, while immunotherapy with Keytruda costs between $22,000 and $32,000. Total expenses depend on the disease stage and treatment cycles. Patients often save 30-50% compared to US costs. Milan remains the top destination for this care.
Typical Hodgkin's Lymphoma Treatment Costs in Italy
Bookimed Expert Insight: Advanced cases requiring specialized care benefit most from centers like San Raffaele in Milan. Dr. Fabio Ciceri leads their hematology unit, specializing in cell and gene therapy clinical trials. This clinic is recognized as one of the world's best hospitals by Newsweek. It offers high-value care for patients needing complex stem cell therapies. Multidisciplinary teams here integrate research with patient treatment for better outcomes.
| Italy | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $7,000 | from $7,000 | from $12,000 |
| Chemotherapy for breast cancer | from $4,500 | from $1,200 | from $15,000 |
| Chemotherapy | from $3,500 | from $2,430 | from $2,500 |
| Biological therapy | from $18,000 | from $5,500 | from $20,000 |
| Immunotherapy with Keytruda (Pembolizumab) | from $22,000 | from $3,300 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Hodgkin's lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hodgkin's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hodgkin's lymphoma treatment journey.
Head of Hematology and Bone Marrow Transplantation at San Raffaele – Professor Ciceri leads clinical trials in cell and gene therapy for hematological cancers.
The doctor serves as the Deputy Director of the Hematology Oncology Department and Director of the Lymphoma Unit at the San Raffaele Scientific Institute, with a focus on lymphoma treatment.
He is the founder of the Italian Lymphoma Foundation, dedicated to advancing clinical studies in lymphoma management.
His academic background includes a degree in general medicine and surgery from the University of Buenos Aires and the University of Parma, and a specialty in medical oncology from the University of Milan.
The doctor has authored over 300 papers on lymphoma treatment and is a member of several prestigious hematology and oncology societies.